Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 10, 2017 | Orphazyme | $14.9M Series B Extension | — | ALS Investment Fund, Idinvest Partners, Kurma Partners, LSP, Novo Holdings, Sunstone Capital |
| Feb 11, 2015 | Orphazyme | $22.6M Series B | Rémi Droller | Idinvest Partners, Novo Holdings, Sunstone Capital |
| Oct 1, 2013 | F-Star Therapeutics | $9.0M Star Therapeutics - Series A | — | Atlas Venture, INKEF Capital, MP Healthcare Venture Management, MS Ventures, SR One, TVM Capital |
| Nov 17, 2011 | Biocartis | $96.0M Series C | — | Dinko Valerio, Rudi Pauwels, Rudi Maris, Pietro Scalfaro, Luc Verelst, Staf Van Reet, Vincent Vliebergh, Greg Parekh, Philips, PMV, alex dittmair |
| Sep 9, 2011 | Orphazyme | $19.1M Series A | — | Hakan Goker, Peter Moldt, Sunstone Capital |
| Apr 13, 2011 | F-Star Therapeutics | $21.7M Star Therapeutics - Other Equity | Deborah Harland | Atlas Venture, MP Healthcare Venture Management, M Ventures, Novo Ventures, Axel Polack |
| Apr 1, 2010 | Biocartis | $40.0M Series B | Dinko Valerio | Advent Life Sciences, Advent Venture Partners, Rudi Pauwels, Biovest, Pietro Scalfaro, Johnson & Johnson Innovation |
| Mar 22, 2010 | Affectis Pharmaceuticals | $4.5M Series D | — | Bayernkapital, EMBL Ventures, KfW, LSP |
| Jan 1, 2010 | F-Star Therapeutics | $12.0M Star Therapeutics - Series A | MP Healthcare Venture Management, M Ventures | Atlas Venture, INKEF Capital, Novo Ventures, TVM Capital |
| Oct 1, 2009 | Biocartis | $15.0M Series A | Dinko Valerio | Advent Life Sciences, Raj Parekh, Peter Verhaeghe, Rudi M. Marien, Ruth Devenyns |